Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis | Zendy

Roberto Catanzaro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis

Author(s) -

Roberto Catanzaro

Publication year - 2013

Publication title -

drug discoveries and therapeutics

Language(s) - English

Resource type - Journals

eISSN - 1881-784X

pISSN - 1881-7831

DOI - 10.5582/ddt.2013.v7.5.196

Subject(s) - apoptosis , cell cycle , cell growth , in vitro , cancer research , cell cycle checkpoint , gene , cell culture , cell , chemistry , limiting , cell cycle progression , microbiology and biotechnology , cancer , biology , biochemistry , genetics , mechanical engineering , engineering

The aim of this study was to test for a potential anticarcinogenic effect of Celergen, a marine derivative devoid of traceable amounts of inorganic arsenic, on cell proliferation, cell cycle progression and apoptosis in the HepG2 human liver cancer cell line. Celergen significantly inhibited the proliferation of cancer cells in a dose-dependent manner while limiting the cell cycle progression at the G1 phase and significantly inducing apoptosis. Further examination showed that Celergen enhanced expression of the p21CIPl1WAF1, GADD153 genes and downregulated the c-myc gene. These results suggest that Celergen exerts promising chemopreventive properties to be further investigated

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research